Amanda Leonberg-Yoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Amanda Leonberg-Yoo has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Ty Blink Dunn
Medical College of Wisconsin, Milwaukee, USA
2 shared publications - Abigail Forte
Department of Pharmacy Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA
1 shared publication - Alaina Thorne
University of Notre Dame, Notre Dame, IN
1 shared publication - Anish Kumar Agarwal
Department of Emergency Medicine, University of Pennsylvania, Philadelphia, PA
1 shared publication - Clara Wilson
Renal-Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA
1 shared publication - Daniel J. Lee
Division of Urology, University of Pennsylvania, Philadelphia, PA
1 shared publication
Latest Publications
- Open Access
- 24 August 2026
- Published by Wolters Kluwer Health in Kidney360
Underutilization of Preemptive Waitlisting for Prior Living Donors Who Develop ESKD
Was not provided for this article.
- 24 August 2026
- Published by Wolters Kluwer Health in Kidney360
Open AccessUnderutilization of Preemptive Waitlisting for Prior Living Donors Who Develop ESKD
Was not provided for this article.
- Open Access
- 7 May 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (6) , e1954
Patient-reported Opioid use and Pain Management After Living Kidney Donation
Background.: This study evaluated donor-reported opioid use and pain management outcomes after living donor nephrectomy at a single center. Prospective data were collected through an automated text-messaging platform to assess postdischarge pain intensity, perceived pain control, and use of prescribed opioids for acute postoperative pain. Methods.: This prospective study was conducted at a large academic health system in Pennsylvania. Eligible participants were adult living kidney donors (aged 18 y and older) who underwent donor nephrectomy between July 2021 and March 2023. Data were collected using an automated text-messaging system from hospital discharge through postoperative day 28. Results.: Of the eligible participants, 75 (71%) consented to participate. Donors who consented to follow-up did not differ significantly from those who did not consent in terms of demographic or perioperative characteristics. Inpatient opioid use and discharge prescribing practices were similar across groups. Of participants who responded at each follow-up, the median (interquartile range) self-reported pain intensity on day 4 was 4.0 (3.0–5.0) and decreased to 1.0 (0.0–2.0) by day 21. The median (interquartile range) perceived pain control increased to 10.0 (9.0–10.0) by day 14, with 3 (8.1%) of participants reporting opioid use by this time. Conclusions.: From a systems perspective, these findings underscore the need to recalibrate default discharge prescribing practices. Implementing standardized order sets and feedback mechanisms may reduce excess opioid supply while maintaining living kidney donor comfort.
- 7 May 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (6) , e1954
Open AccessPatient-reported Opioid use and Pain Management After Living Kidney Donation
Background.: This study evaluated donor-reported opioid use and pain management outcomes after living donor nephrectomy at a single center. Prospective data were collected through an automated text-messaging platform to assess postdischarge pain intensity, perceived pain control, and use of prescribed opioids for acute postoperative pain. Methods.: This prospective study was conducted at a large academic health system in Pennsylvania. Eligible participants were adult living kidney donors (aged 18 y and older) who underwent donor nephrectomy between July 2021 and March 2023. Data were collected using an automated text-messaging system from hospital discharge through postoperative day 28. Results.: Of the eligible participants, 75 (71%) consented to participate. Donors who consented to follow-up did not differ significantly from those who did not consent in terms of demographic or perioperative characteristics. Inpatient opioid use and discharge prescribing practices were similar across groups. Of participants who responded at each follow-up, the median (interquartile range) self-reported pain intensity on day 4 was 4.0 (3.0–5.0) and decreased to 1.0 (0.0–2.0) by day 21. The median (interquartile range) perceived pain control increased to 10.0 (9.0–10.0) by day 14, with 3 (8.1%) of participants reporting opioid use by this time. Conclusions.: From a systems perspective, these findings underscore the need to recalibrate default discharge prescribing practices. Implementing standardized order sets and feedback mechanisms may reduce excess opioid supply while maintaining living kidney donor comfort.
- Open Access
- 1 October 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (2) , 397-407
Strategic Innovations to Reduce Disincentives and Increase Living Kidney Donation
Key Points: Innovations targeting living kidney donor disincentives increase living kidney donation. By addressing known barriers, these programs can expand the donor pool, improve efficiency in donor evaluation, and improve donor experience. Background: While up to 59% of the US population report willingness to donate a kidney, only about 6000 living kidney donations (LKD) occur annually. This study described the use and impact of National Kidney Registry (NKR) programs designed to eliminate disincentives to LKD. Methods: This was a retrospective cohort analysis using administrative data records from the NKR, a national database capturing information on potential living kidney donors at 103 transplant centers across the continental United States. Descriptive statistics were used to summarize donor characteristics, program participation, and outcome measures. An interrupted time series was used to analyze changes in registration conversion rates before and after program implementation. Results: After the implementation of Donor Connect, the registration conversion rate increased from 8.4% immediately preceding implementation to 18.4% by the end of follow-up. At the time of intervention, a statistically significant 8% increase in registration conversion rate was observed ( P < 0.001), with an additional 0.3% increase per quarter thereafter ( P = 0.017). Remote donors were significantly more likely to live >150 miles from the recipient's transplant center (84% versus 21%); the Remote Donor Program reduced travel burden by 597 [205, 1196] miles. Referral conversion rates were significantly higher for donors living within 50 miles (8.3%) compared with those 51–150 miles (6.5%, P < 0.001) and >150 miles (5.3%, P < 0.003), corresponding to an increased donation odds of 1.31 and 1.62, respectively). Fifty-one percent of donors received cost reimbursement through the Donor Shield program. Donors who participated were more racially diverse and were more likely to reside further from the transplant center. Conclusions: This analysis indicates that the outcomes from NKR's programs support the efficacy of disincentive-targeted innovations as a way to increase donation rates by supporting donors and streamlining the donation process. These innovations represent a modern, donor-centered approach to LKD. By addressing known barriers, these programs have the potential to expand the donor pool, improve the efficiency in donor evaluation, and improve the overall donor experience. Podcast: This article contains a podcast at https://dts.podtrac.com/redirect.mp3//www.asn-online.org/media/podcast/JASN/2026_02_09_KTS_February2026.mp3
- 1 October 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (2) , 397-407
Open AccessStrategic Innovations to Reduce Disincentives and Increase Living Kidney Donation
Key Points: Innovations targeting living kidney donor disincentives increase living kidney donation. By addressing known barriers, these programs can expand the donor pool, improve efficiency in donor evaluation, and improve donor experience. Background: While up to 59% of the US population report willingness to donate a kidney, only about 6000 living kidney donations (LKD) occur annually. This study described the use and impact of National Kidney Registry (NKR) programs designed to eliminate disincentives to LKD. Methods: This was a retrospective cohort analysis using administrative data records from the NKR, a national database capturing information on potential living kidney donors at 103 transplant centers across the continental United States. Descriptive statistics were used to summarize donor characteristics, program participation, and outcome measures. An interrupted time series was used to analyze changes in registration conversion rates before and after program implementation. Results: After the implementation of Donor Connect, the registration conversion rate increased from 8.4% immediately preceding implementation to 18.4% by the end of follow-up. At the time of intervention, a statistically significant 8% increase in registration conversion rate was observed ( P < 0.001), with an additional 0.3% increase per quarter thereafter ( P = 0.017). Remote donors were significantly more likely to live >150 miles from the recipient's transplant center (84% versus 21%); the Remote Donor Program reduced travel burden by 597 [205, 1196] miles. Referral conversion rates were significantly higher for donors living within 50 miles (8.3%) compared with those 51–150 miles (6.5%, P < 0.001) and >150 miles (5.3%, P < 0.003), corresponding to an increased donation odds of 1.31 and 1.62, respectively). Fifty-one percent of donors received cost reimbursement through the Donor Shield program. Donors who participated were more racially diverse and were more likely to reside further from the transplant center. Conclusions: This analysis indicates that the outcomes from NKR's programs support the efficacy of disincentive-targeted innovations as a way to increase donation rates by supporting donors and streamlining the donation process. These innovations represent a modern, donor-centered approach to LKD. By addressing known barriers, these programs have the potential to expand the donor pool, improve the efficiency in donor evaluation, and improve the overall donor experience. Podcast: This article contains a podcast at https://dts.podtrac.com/redirect.mp3//www.asn-online.org/media/podcast/JASN/2026_02_09_KTS_February2026.mp3
- Open Access
- 19 June 2024
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 7 (7) , 637-646
Retrospective assessment of medication patterns among candidates evaluated for living kidney donation
- 19 June 2024
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 7 (7) , 637-646
Open AccessRetrospective assessment of medication patterns among candidates evaluated for living kidney donation
- Open Access
- 1 July 2021
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 78 (1) , 9-12
Lessons Learned: Nephrology Training Program Adaptation in the Time of COVID
- 1 July 2021
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 78 (1) , 9-12
Open AccessLessons Learned: Nephrology Training Program Adaptation in the Time of COVID